​​​​​Lord Prior addressed a gathering of more than 100 of the UK’s leading medicines manufacturer’s at the Medicines Manufacturing Industry Partnership (MMIP) conference bringing together experts from across the industry.

Andy Evans, Chair of MMIP and Head of Macclesfield Site at AstraZeneca said:

“​The UK has significant strengths in the Life Sciences Sector but there is an opportunity to drive further growth in manufacturing jobs and exports in this sector building on the excellence of the Research and Development base in the UK. There are opportunities in the emerging area of Advanced Therapy Manufacturing and also through investing in Advanced Manufacturing to revolutionise medicines manufacture.

“With a gross value added (GVA) more than three times the UK average, the medicines manufacturing industry can play a crucial role in solving our country’s productivity puzzle, providing highly-skilled fit-for-the-future jobs and powering economic growth across the UK.

“Working together in partnership with Government to develop the new Industrial Strategy for Life Sciences, the medicines manufacturing industry wants to ensure the economy, our businesses and workers, and UK patients, all benefit from investing in this potential.”